It is considered that growth factors and cytokines produced by cancer cells within the tumor microenvironment might activate G-CSF in tumor and stromal cells because activation of the RAS/RAF/MEK pathway resulted in enhanced G-CSF expression [29]. The gene discussed is CSF3; the disease is cancer.